• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Tuesday, May 30, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Tracking chirality in real time

Bioengineer by Bioengineer
May 26, 2022
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Chiral molecules exist in two forms, called enantiomers, which are mirror images of each other and non-superposable – much like a pair of hands. While they share most chemical and physical properties, enantiomers can have adverse effects in (bio)chemical phenomena. For example, a protein or enzyme may only bind one enantiomeric form of a target molecule. Consequently, identification and control of chirality is often key to designing (bio)chemical compounds, e.g. in the food, fragrance, and pharmaceutical industries. 

Time-resolved circular dichroism measurement of a photoexcited spin-crossover complex

Credit: Ella Maru Studio, Inc.

Chiral molecules exist in two forms, called enantiomers, which are mirror images of each other and non-superposable – much like a pair of hands. While they share most chemical and physical properties, enantiomers can have adverse effects in (bio)chemical phenomena. For example, a protein or enzyme may only bind one enantiomeric form of a target molecule. Consequently, identification and control of chirality is often key to designing (bio)chemical compounds, e.g. in the food, fragrance, and pharmaceutical industries. 

A most common technique for detecting chirality is called circular dichroism, which measures how chiral samples absorb left- and right-circularly polarized light differently to directly identify pairs of enantiomers. Circular dichroism can also help resolve the conformation of a molecule through its chiral response – a feature that has made it a popular analytical tool in (bio)chemical sciences.

However, circular dichroism has so far been limited in time-resolution and spectral range. Researchers led by Malte Oppermann in the group of Majed Chergui at EPFL, have now developed a new time-resolved instrument that measures circular dichroism changes in fractions of a picosecond (one trillionth of a second), meaning that it can “take” ultrafast snapshots of a molecule’s chirality throughout its (bio)chemical activity. This makes it possible to capture the chirality of photoexcited molecules and to resolve the conformational motion that drives the conversion of the absorbed light energy.

In a collaboration with the group of Jérôme Lacour at the University of Geneva and Francesco Zinna at the University of Pisa, the researchers used the new method to investigate the magnetic-switching dynamics of so-called “iron-based spin-crossover complexes” – an important class of metallo-organic molecules with promising applications in magnetic data storage and processing devices. After decades of research, the deactivation mechanism of their magnetic state has remained unresolved, despite its importance for magnetic data storage.

Carrying out a time-resolved circular dichroism experiment, the researchers discovered that the loss of magnetization is driven by a twisting of the molecule’s structure that distorts its chiral symmetry. Remarkably, the team was also able to slow down the decay of the magnetic state by suppressing the twisting motion in modified complexes.

“These ground-breaking experiments show that time-resolved circular dichroism is uniquely suited to capture the molecular motion that drives many (bio)chemical processes,” says Malte Oppermann. “This offers a new way for investigating challenging dynamic phenomena – for example the ultrafast rotations of synthetic molecular motors, and the conformational changes of proteins and enzymes in their native liquid environment.”



Journal

Nature Chemistry

DOI

10.1038/s41557-022-00933-0

Article Title

Chiral control of spin-crossover dynamics in Fe(II) complexes

Article Publication Date

26-May-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

Photo

Scientists identify how some angiogenic drugs used to treat cancer and heart disease cause vascular disease

May 30, 2023
Potential new therapeutic targets in NKTL

CSI Singapore researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

May 30, 2023

Deconstructing the role of MALAT1 in MAPK-Signaling in melanoma

May 30, 2023

Biological specimens imaged with X-rays without damage

May 30, 2023

POPULAR NEWS

  • plants

    Plants remove cancer causing toxins from air

    39 shares
    Share 16 Tweet 10
  • Element creation in the lab deepens understanding of surface explosions on neutron stars

    36 shares
    Share 14 Tweet 9
  • Groundbreaking study uncovers first evidence of long-term directionality in the origination of human mutation, fundamentally challenging Neo-Darwinism

    115 shares
    Share 46 Tweet 29
  • How life and geology worked together to forge Earth’s nutrient rich crust

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Scientists identify how some angiogenic drugs used to treat cancer and heart disease cause vascular disease

CSI Singapore researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

Deconstructing the role of MALAT1 in MAPK-Signaling in melanoma

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 50 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In